Either vaccine is more than 80% effective at preventing hospital admission three to four weeks after first dose, PHE finds
A single shot of the Pfizer/BioNTech or Oxford/AstraZeneca vaccine offers dramatic protection against hospital admission and severe disease in older people, according to a new study from Public Health England (PHE).
Matt Hancock hailed the real-world data, which found either vaccine is more than 80% effective at preventing hospital admission around three to four weeks after the first dose.
